InsideTrading SEC Form 4 insider trades

Stocks

AVIR Atea Pharmaceuticals, Inc.

Healthcare · Market cap: $344.9M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $214.7K 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $488.0K 2024-Q2: bought $0, sold $65.3K 2024-Q3: bought $0, sold $234.2K 2024-Q4: bought $0, sold $1.0M 2025-Q1: bought $81.4K, sold $0 2025-Q2: bought $25.4K, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $25.4K, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $81.4K) Sold, below the line (largest quarter $1.0M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$214.7K
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$488.0K
2024-Q2$0$65.3K
2024-Q3$0$234.2K
2024-Q4$0$1.0M
2025-Q1$81.4K$0
2025-Q2$25.4K$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$0
2026-Q2$25.4K$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$235.2K5 buy days
Sold$2.0M14 sell days
Net insider flow-$1.8Mnet selling · 5 years
Latest trade2026-05-18Murphy Polly A.
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-05-18 Buy Murphy Polly A. Director 6,100 $4.17 $25.4K 1
2025-05-18 Buy Murphy Polly A. Director 6,100 $4.17 $25.4K 1
2025-01-16 Buy BERGER FRANKLIN M Director 10,000 $3.36 $33.6K 1
2025-01-15 Buy BERGER FRANKLIN M Director 15,000 $3.19 $47.8K 1
2024-12-10 Sell BERGER FRANKLIN M Director 359,606 $2.85 $1.0M 1
2024-09-19 Sell Sommadossi Jean-Pierre CEO 1,841 $4.00 $7.4K 1
2024-09-18 Sell Sommadossi Jean-Pierre CEO 22,187 $4.03 $89.4K 1
2024-09-17 Sell Sommadossi Jean-Pierre CEO 33,941 $4.05 $137.5K 1
2024-06-20 Sell Polsky Bruce Director 17,544 $3.49 $61.2K 1
2024-06-05 Sell Sommadossi Jean-Pierre CEO 1,006 $4.00 $4.0K 1
2024-02-01 Sell Sommadossi Jean-Pierre CEO 56,910 $3.85 $219.1K 1
2024-02-01 Sell Horga Maria Arantxa Other C-suite 15,870 $3.84 $60.9K 1
2024-02-01 Sell Corcoran Andrea Other officer 15,843 $3.84 $60.8K 1
2024-02-01 Sell Hammond Janet MJ Other C-suite 14,029 $3.84 $53.9K 1
2024-02-01 Sell Foster Wayne Other C-suite 12,477 $3.84 $47.9K 1
2024-02-01 Sell Vavricka John Other C-suite 11,819 $3.84 $45.4K 1
2022-11-14 Sell BERGER FRANKLIN M Director 16,166 $5.16 $83.4K 1
2022-11-11 Sell BERGER FRANKLIN M Director 25,500 $5.15 $131.3K 1
2021-12-20 Buy Murphy Polly A. Director 12,000 $8.57 $102.8K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
BERGER FRANKLIN M Director $81.4K $1.2M 2025-01-16
Sommadossi Jean-Pierre CEO $0 $457.4K 2024-09-19
Murphy Polly A. Director $153.7K $0 2026-05-18
Polsky Bruce Director $0 $61.2K 2024-06-20
Horga Maria Arantxa Other C-suite $0 $60.9K 2024-02-01
Corcoran Andrea Other officer $0 $60.8K 2024-02-01
Hammond Janet MJ Other C-suite $0 $53.9K 2024-02-01
Foster Wayne Other C-suite $0 $47.9K 2024-02-01
Vavricka John Other C-suite $0 $45.4K 2024-02-01

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2020-11-03 3 $13.0M 44 -13.9% (-8.2% raw)+172.4% (+184.7% raw)-57.4% (-36.8% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.